ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.069

$0.001 (1.43%)

Day Range

$0.069 - $0.070

52 Week Range

$0.065 - $0.125

Volume

48.80K

Avg Volume (10D)

649.68K

Market Cap

$83.30M

Price Chart

Market Statistics

Open$0.070

Previous Close$0.070

Day High$0.070

Day Low$0.069

52 Week High$0.125

52 Week Low$0.065

Valuation

Market Cap83.30M

Shares Outstanding1.21B

Price to Book4.44

Trading Activity

Volume48.80K

Value Traded3.41K

Bid$0.067 × 81,945

Ask$0.073 × 200,000

Performance

1 Day0.00%

5 Day4.48%

13 Week-24.73%

52 Week-13.58%

YTD-24.73%

Technical Indicators

RSI (14)38.12

50-Day SMA$0.082

200-Day SMA$0.089

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton